Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07437872 · ClinicalTrials.gov registry record · NA
Testing Mechanisms of Virtual Reality Exposure Therapy for Social Anxiety
A NA study of no Interaction VRET and Scripted Interactions VRET, sponsored by Palo Alto University.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT07437872 is a NA study of no Interaction VRET and Scripted Interactions VRET that is actively recruiting participants, run by Palo Alto University. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07437872, a NA study of no Interaction VRET and Scripted Interactions VRET, is actively recruiting participants, sponsored by Palo Alto University.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test mechanisms and processes of virtual reality and augmented reality exposure therapy for social anxiety. There is substantial evidence that virtual reality exposure therapy is an effective treatment for social anxiety. However, it can be difficult to access treatment that needs to be conducted in person. Tests of self-guided (without therapist assistance) virtual reality exposure therapy have had mixed efficacy and tests of augmentation offer an important method to optimize brief interventions. The study objectives are to test a wide range of possible mechanisms and approaches (ranging from single sessions in person to remotely conducted virtual reality exposure therapy) in order to advance the field. The broadness of the proposed research is to provide multiple avenues for inquiry per discussion with IRB chair Dr. Kuo. Depending on the specific line of inquiry some variations will be documented (e.g., multiple consent forms for answering different sub questions of the primary questions listed below).
Conditions Studied
Interventions
- BEHAVIORAL ExpandXR
Study Locations (1)
California
- Palo Alto University Mountain View Campus - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-02-24 |
| Est. Completion | 2028-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07437872
The ClinicalTrials.gov registry entry for NCT07437872 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto University, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with no Interaction VRET appearing as the primary indexed condition, and to 1 intervention - of which ExpandXR is the first listed.
NCT07437872 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07437872 about?
NCT07437872 is a clinical study titled "Testing Mechanisms of Virtual Reality Exposure Therapy for Social Anxiety". The purpose of this study is to test mechanisms and processes of virtual reality and augmented reality exposure therapy for social anxiety. There is substantial evidence that virtual reality exposure therapy is an effective treatment for social anxiety. However, it can be difficult to access treatme...
What is the current status of trial NCT07437872?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-02-24. Estimated completion is 2028-03-01.
What conditions does trial NCT07437872 study?
This clinical trial studies the following conditions: no Interaction VRET, Scripted Interactions VRET, Fully Customized Interactions VRET.
What interventions are being tested in trial NCT07437872?
The interventions under investigation include: ExpandXR (BEHAVIORAL).
Who is sponsoring clinical trial NCT07437872?
This trial is sponsored by Palo Alto University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07437872 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.